A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 49
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : GLD
Long Form : greatest linear dimension
No. Year Title Co-occurring Abbreviation
2019 Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with acute welding arc maculopathy. BCVA, CMT, EZ, SD-OCT
2019 The Comparison of Morphologic Characteristics of Type 1 and Type 2 Choroidal Neovascularization in Eyes with Neovascular Age-Related Macular Degeneration using Optical Coherence Tomography Angiography. CNV, GVC, nAMD, OCTA
2017 Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy. BCVA, IVR, PCV, PDT, VEGF
2017 Evaluating role of bone marrow-derived stem cells in dry age-related macular degeneration using multifocal electroretinogram and fundus autofluorescence imaging. AMD, BCVA, BM-HSCs, GA, mfERG
2017 Focal choroidal excavation-morphological features and clinical correlation. FCE, PCV
2016 Cross-sectional pupillographic evaluation of relative afferent pupillary defect in age-related macular degeneration. AMD, RAPD
2016 Multimodal Image Analysis in Acquired Vitelliform Lesions and Adult-Onset Foveomacular Vitelliform Dystrophy. AOFVD, AVL, FA, FAF, LH, SD-OCT, VLs
2016 Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography. BCVA, CSMT, nAMD, PDT, SS-OCT
2015 CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. CNV, OCTA, RPED
10  2015 Quantitative Analysis of Segmented Fluorescein Angiography Images for the Follow-up of Choroidal Neovascular Membrane. C-G, CMT, CNV, FA, VA
11  2015 The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients. PCV, RPE, SD
12  2014 Comparison of the outcomes of photodynamic therapy between two angiographic subtypes of polypoidal choroidal vasculopathy. BCVA, PCV, PDT
13  2014 Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. BCVA, PCV, PDT, PDT, VEGF
14  2014 Level of vascular endothelial growth factor 165b in human aqueous humor. AMD, CFT, CNV, ELISA, PCV, RVO, SRF, VEGF165b
15  2013 Choroidal neovascularization in 36 eyes of children and adolescents. BCVA, CNV, FFA
16  2013 Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy. BCVA, CNV, PDT
17  2013 Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD). AMD, BCVA, CNV, CRT, IVR, PDT
18  2013 Visual outcome of photodynamic therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy over 5 years of follow-up. BCVA, PCV, PDT, post-PDT, tAMD
19  2013 [Comparison of 1-year treatment outcome of intravitreal pegaptanib sodium versus bevacizumab for myopic choroidal neovascularization]. mCNV
20  2012 Comparison between anti-vascular endothelial growth factor therapy and photodynamic therapy for myopic choroidal neovascularization. BCVA, CRT, mCNV, ONL, PDT, PDT, VEGF
21  2012 Vision, retinal thickness, and foveal avascular zone size after intravitreal bevacizumab for diabetic macular edema. CMT, DME, DR, FAZ, IVB, VA
22  2011 Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapy. PCV, PDT, SNPs
23  2011 The association of age-related maculopathy susceptibility 2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. ARMS2, BCVA, PCV, PDT, tAMD
24  2011 Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy. AMD, OR, PCV, PDT, PVD, RR, SD-OCT, VMA
25  2010 Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration. AMD, BCVA, CRT, OCT
26  2010 Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. BCVA, IVB, PDT
27  2010 [Outcome of photodynamic therapy for exudative age-related macular degeneration with good visual acuity]. AMD, OCT, PDT, VA
28  2009 Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study. IVTA, PDT
29  2009 Physician assessment of changing lesion size of predominantly classic choroidal neovascular membranes in age-related macular degeneration. ---
30  2009 The effect of the first application of verteporfin photodynamic therapy on lesion growth in choroidal neovascularisation and its potential impact on combination therapy. CNV, PDT, TAP, vPDT
31  2009 [Clinical features of vitreous hemorrhage after photodynamic therapy for age-related macular degeneration]. AMD, PDT, VH
32  2008 Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration. AMD, BCVA, CNV, PDT
33  2008 Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization? DS, NL, PDT, SFCNV
34  2008 One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. AMD, ETDRS, FA, PCV, VA
35  2008 Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degeneration. AMD, BCVA, CNV, VT
36  2008 The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. GA
37  2007 Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study. AMD, CNV
38  2007 Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. CNV, FA, ICGA, OCT, PCV, PDT, VA
39  2007 Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study. BCVA, CRT
40  2007 Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. CNV, PDT
41  2007 [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients]. AE
42  2006 Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks. AS, CNV, PDT, VA
43  2005 Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration. ---
44  2005 Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration. AMD, BCVA, CNV, FA, PDT
45  2005 Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. BCVA, CNV, PDT
46  2004 Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration. AMD, CNV, DA, DD, MPS, PDT, VIP
47  2004 Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. AMD, CNV, iTAAC, PDT
48  2003 Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. CNV, ETDRS
49  2002 Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. CNV, OHS